I agree that this site is using cookies. You can find further informations here.
X
Gladiator, André
23  results:
Search for persons X
?
1

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
Advances in Therapy.  40 (2023)  12 - p. 5168-5187 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Development of a primary care screening algorithm for the e..:

Messelink, Marianne A. ; Berbers, Roos M. ; van Montfrans, Joris M....
Allergy, Asthma & Clinical Immunology.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
3

Correction: Transitioning subcutaneous immunoglobulin 20% t..:

Keith, Paul K. ; Cowan, Juthaporn ; Kanani, Amin...
Allergy, Asthma & Clinical Immunology.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Transitioning subcutaneous immunoglobulin 20% therapies in ..:

Keith, Paul K. ; Cowan, Juthaporn ; Kanani, Amin...
Allergy, Asthma & Clinical Immunology.  18 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Infusion parameters of 20% subcutaneous immunoglobulin for ..:

Meckley, Lisa M. ; Wu, Yanyu ; Tzivelekis, Spiros..
Annals of Allergy, Asthma & Immunology.  127 (2021)  5 - p. 568-574.e1 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Infusion Parameters of Patients Initiated on Ig20Gly in a P..:

Meckley, Lisa ; Wu, Yanyu ; Tzivelekis, Spiros..
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB216 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Antigen-Specific Th17 Cells Are Primed by Distinct and Comp..:

Trautwein-Weidner, Kerstin ; Gladiator, André ; Kirchner, Florian R....
PLOS Pathogens.  11 (2015)  10 - p. e1005164 , 2015
Link: https://doi.org/10.1371/..
 
?
8

Arming Th17 Cells for Antifungal Host Defense:

Gladiator, André ; Trautwein-Weidner, Kerstin ; Bär, Eva.
Current Fungal Infection Reports.  7 (2013)  2 - p. 138-143 , 2013
Link: https://doi.org/10.1007/..
 
?
9

Innate Lymphoid Cells: New Players in IL-17-Mediated Antifu..:

Gladiator, André ; LeibundGut-Landmann, Salomé ; Goldman, William E.
PLoS Pathogens.  9 (2013)  12 - p. e1003763 , 2013
Link: https://doi.org/10.1371/..
 
?
10

Correction: Transitioning subcutaneous immunoglobulin 20% t..:

Keith, Paul K ; Cowan, Juthaporn ; Kanani, Amin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290310/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Development of a primary care screening algorithm for the e..:

Messelink, Marianne A ; Berbers, Roos M ; van Montfrans, Joris M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224324/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
https://boris.unibe.ch/186629/.  , 2023
Link: https://boris.unibe.ch/1..
 
?
13

Real-World Use, Safety, and Patient Experience of 20% Subcu..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611600/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Real-world utilization, safety and patient experience of 20..:

Fasshauer, Maria ; Borte, Michael ; Bitzenhofer, Michaela...
https://boris.unibe.ch/175541/.  , 2022
Link: https://boris.unibe.ch/1..
 
?
15

Transitioning subcutaneous immunoglobulin 20% therapies in ..:

Keith, Paul K ; Cowan, Juthaporn ; Kanani, Amin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358831/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15